Neilshan Loedy on Muck Rack

Neilshan Loedy

As seen in: medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Neilshan

Contact Neilshan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Role of Frailty in Shaping Social Contact Patterns in Belgium, 2022-2023

|
By Neilshan Loedy, Andrea Torneri, Lisa Hermans, Maikel Bosschaert
| medRxiv
The authors have declared no competing interest. Funding for this study [study number: 215366] was provided by GSK. GSK was provided the opportunity to review a preliminary version of this publication for factual accuracy, but the authors are solely responsible for final content and interpretation. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (44) Issue with article?

An extension of the Benefit Risk Assessment of VaccinEs (BRAVE) Toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union

|
By Neilshan Loedy, Jonas Crèvecoeur, Hector Gonzalez Dorta, Abrams Steven
| medRxiv
HGD, DRM, CC, XK and CQ were employees of the European Medicines Agency at the time of elaboration of this work and have no conflict of interest. HGD is a co-founder and holds stock options in Rynd Biotech, a startup company for the rapid detection of sexually transmitted infections.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified